Register entry
Alcon Laboratories, Inc
- Registered sites
- 3
- Drug products
- 56
- Live patents
- 61
- Countries
- 2
- Base
- United States
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Finished drug manufactureRelabellingRepackaging
Sites
Facilities
3| Site | Location | Operations | FEI |
|---|---|---|---|
| Alcon Singapore Manufacturing Pte. Ltd. | SGSingapore | Finished drug manufacture | 3010372291 |
| Alcon Vision, LLC | Elkridge, MDUnited States | Repackaging | 3000215259 |
| Alcon Research LLC | Fort Worth, TXUnited States | Finished drug manufacture, Relabelling, Repackaging | 1610287 |
Exclusivity
Patents
61Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| EYSUVIS | LOTEPREDNOL ETABONATE | May 2033 |
| INVELTYS | LOTEPREDNOL ETABONATE | May 2033 |
| PATADAY ONCE DAILY RELIEF | OLOPATADINE HYDROCHLORIDE | May 2032 |
| RHOPRESSA | NETARSUDIL MESYLATE | Jan 2030 |
| RHOPRESSA | NETARSUDIL MESYLATE | Nov 2030 |
| RHOPRESSA | NETARSUDIL MESYLATE | Mar 2034 |
| ROCKLATAN | LATANOPROST; NETARSUDIL DIMESYLATE | Jan 2030 |
| ROCKLATAN | LATANOPROST; NETARSUDIL DIMESYLATE | Nov 2030 |
| ROCKLATAN | LATANOPROST; NETARSUDIL DIMESYLATE | Mar 2034 |
| SIMBRINZA | BRIMONIDINE TARTRATE; BRINZOLAMIDE | Jun 2030 |
| SIMBRINZA | BRIMONIDINE TARTRATE; BRINZOLAMIDE | Oct 2030 |
| TRYPTYR | ACOLTREMON | Sept 2031 |
| TRYPTYR | ACOLTREMON | Dec 2042 |
Catalogue
Marketed products
56Showing 56 of 56.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| Alcaine | proparacaine hydrochloride | SOLUTION/ DROPS | ANDA |
| Alcon Tears Lubricant Eye Drops | hypromellose 2910 | SOLUTION/ DROPS | OTC MONOGRAPH DRUG |
| BION TEARS | Dextran, Hypromellose | SOLUTION/ DROPS | OTC MONOGRAPH DRUG |
| BION TEARS | Dextran, Hypromellose | SOLUTION/ DROPS | OTC MONOGRAPH DRUG |
| BSS | balanced salt solution | SOLUTION | NDA |
| BSS | balanced salt solution | SOLUTION | NDA |
| BSS PLUS | balanced salt solution enriched with bicarbonate, dextrose, and glutathione | KIT | NDA |
| Betadine | povidone-iodine | SOLUTION | NDA |
| Cyclogyl | cyclopentolate hydrochloride | SOLUTION/ DROPS | ANDA |
| Cyclogyl | cyclopentolate hydrochloride | SOLUTION/ DROPS | ANDA |
| Cyclogyl | cyclopentolate hydrochloride | SOLUTION/ DROPS | ANDA |
| Cyclomydril | cyclopentolate hydrochloride and phenylephrine hydrochloride | SOLUTION/ DROPS | ANDA |
| Eysuvis | loteprednol etabonate | SUSPENSION/ DROPS | NDA |
| FLUORESCITE | fluorescein sodium | INJECTION, SOLUTION | NDA |
| GenTeal Tears (Moderate) | Dextran 70, Glycerin, Hypromellose | SOLUTION/ DROPS | OTC MONOGRAPH DRUG |
| GenTeal Tears Gel Drops | polyethylene glycol 400 and propylene glycol | GEL | OTC MONOGRAPH DRUG |
| GenTeal Tears Moderate Preservative Free | dextran 70, hypromellose 2910 | SOLUTION/ DROPS | OTC MONOGRAPH DRUG |
| GenTeal Tears NIGHT-TIME | mineral oil, white petrolatum | OINTMENT | OTC MONOGRAPH DRUG |
| GenTeal Tears Severe | Hypromellose | GEL | OTC MONOGRAPH DRUG |
| Inveltys | Loteprednol Etabonate | SUSPENSION | NDA |
| Inveltys | loteprednol etabonate | SUSPENSION | NDA |
| Isopto Atropine | atropine sulfate | SOLUTION | NDA |
| MIOSTAT | carbachol | SOLUTION | NDA |
| Mydriacyl | tropicamide | SOLUTION/ DROPS | ANDA |
| Mydriacyl | tropicamide | SOLUTION/ DROPS | ANDA |
| - | NETARSUDIL MESYLATE | POWDER | BULK INGREDIENT |
| Naphcon A | naphazoline hydrochloride and pheniramine maleate | SOLUTION/ DROPS | NDA |
| PATADAY ONCE DAILY RELIEF | OLOPATADINE HYDROCHLORIDE | SOLUTION | NDA |
| PATADAY ONCE DAILY RELIEF | OLOPATADINE HYDROCHLORIDE | SOLUTION | NDA |
| PATADAY TWICE A DAY RELIEF | OLOPATADINE HYDROCHLORIDE | SOLUTION | NDA |
| Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | SOLUTION/ DROPS | NDA |
| Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | SOLUTION/ DROPS | NDA |
| Rhopressa | netarsudil | SOLUTION/ DROPS | NDA |
| Rocklatan | netarsudil and latanoprost ophthalmic solution, 0.02%/0.005% | SOLUTION/ DROPS | NDA |
| SIMBRINZA | brinzolamide/brimonidine tartrate | SUSPENSION/ DROPS | NDA |
| SYSTANE HYDRATION PF PRESERVATIVE FREE | Polyethylene Glycol 400 and Propylene Glycol | SOLUTION/ DROPS | OTC MONOGRAPH DRUG |
| SYSTANE HYDRATION PF PRESERVATIVE FREE | Polyethylene Glycol 400 and Propylene Glycol | SOLUTION/ DROPS | OTC MONOGRAPH DRUG |
| Systane | polyethylene glycol 400 and propylene glycol | GEL | OTC MONOGRAPH DRUG |
| Systane | hypromellose | GEL | OTC MONOGRAPH DRUG |
| Systane Balance | propylene glycol | EMULSION | OTC MONOGRAPH DRUG |
| Systane COMPLETE | propylene glycol | EMULSION | OTC MONOGRAPH DRUG |
| Systane COMPLETE PF | propylene glycol | EMULSION | OTC MONOGRAPH DRUG |
| Systane COMPLETE PF | propylene glycol | EMULSION | OTC MONOGRAPH DRUG |
| Systane Complete PF | Propylene Glycol Emulsion | EMULSION | OTC MONOGRAPH DRUG |
| Systane Day and Night Value Pack | Polyethylene Glycol 400, Propylene Glycol 0.3% | KIT | OTC MONOGRAPH DRUG |
| Systane Lubricant | polyethylene glycol 400 and Propylene Glycol | SOLUTION/ DROPS | OTC MONOGRAPH DRUG |
| Systane Nighttime | mineral oil and white petrolatum | OINTMENT | OTC MONOGRAPH DRUG |
| Systane Pro PF | Propylene Glycol | EMULSION | OTC MONOGRAPH DRUG |
| Systane Pro PF | Propylene Glycol | EMULSION | OTC MONOGRAPH DRUG |
| Systane ULTRA | polyethylene glycol 400 and propylene glycol | SOLUTION/ DROPS | OTC MONOGRAPH DRUG |
| Systane Ultra | Polyethylene Glycol 400 and Propylene Glycol | SOLUTION/ DROPS | OTC MONOGRAPH DRUG |
| Systane Ultra Preservative Free | Polyethylene Glycol 400 and Propylene Glycol | SOLUTION/ DROPS | OTC MONOGRAPH DRUG |
| TRYPTYR | Acoltremon | SOLUTION | NDA |
| Tetracaine Hydrochloride | tetracaine hydrochloride | SOLUTION | NDA |
| Zaditor | ketotifen fumarate | SOLUTION | ANDA |
| atropine sulfate | atropine sulfate | SOLUTION | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.